Viridian Therapeutics, Inc.
← Back to VRDN Overview

Viridian Therapeutics, Inc. (VRDN)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-5.48

Financial Fundamentals

VRDNQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2013-03-31-179.06
2013-06-30-178.22
2013-09-30-109.35
2013-12-31-473.38
2014-03-31-182.68
2014-06-30-32.65
2014-09-30-41.87
2014-12-31-24.44
2015-03-31-17.73
2015-06-30-24.96
2015-09-30-8.95
2015-12-31-10.04
2016-03-31-7.45
2016-06-30-6.82
2016-09-30-11.00
2016-12-31-2.60
2017-03-31-5.15
2017-06-30-9.46
2017-09-30-8.46
2017-12-31-9.10
2018-03-31-9.96
2018-06-30-5.57
2018-09-30-4.60
2018-12-31-2.26
2019-03-31-1.91
2019-06-30-1.93
2019-09-30-0.51
2019-12-31-0.38
2020-03-31-0.63
2020-06-30-2.29
2020-09-30-1.97
2020-12-31-0.18
2021-03-31-1.43
2021-06-30-2.06
2021-09-30-3.28
2021-12-31-1.91
2022-03-31-4.70
2022-06-30-2.72
2022-09-30-5.99
2022-12-31-6.47
2023-03-31-3.94
2023-06-30-4.67
2023-09-30-3.51
2023-12-31-4.05
2024-03-31-5.43
2024-06-30-3.24
2024-09-30-4.93
2024-12-31-4.81
2025-03-31-3.15
2025-06-30-2.83
2025-09-30-12.75
2025-12-31-5.48

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.